Physician profile
Gabe Robin
NPI 1255568481
$972.37
in general payments reported to CMS, 2019-2025
21 companies · $413 in 2025
The $413 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.72 · 2022: $129 · 2023: $168 · 2024: $236 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $816.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $130.48 | 2021-2024 | Yupelri |
| Viatris Specialty LLC | $108.69 | 2025 | Yupelri |
| Astrazeneca Pharmaceuticals Lp | $94.40 | 2024-2025 | Airsupra |
| Lilly USA, LLC | $85.22 | 2023-2025 | Mounjaro |
| Novartis Pharmaceuticals Corporation | $76.83 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $73.26 | 2024-2025 | Trintellix |
| Ardelyx, INC. | $54.80 | 2024-2025 | Ibsrela |
| Novo Nordisk INC | $49.01 | 2023-2025 | Rybelsus, Ozempic |
| Phathom Pharmaceuticals, INC. | $45.65 | 2023-2024 | Voquezna |
| Cepheid | $41.72 | 2025 | Genexpert |
| Abbvie INC. | $36.76 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.39 | 2022 | |
| Amgen INC. | $18.31 | 2025 | Repatha, Otezla |
| Verona Pharma, INC. | $17.90 | 2025 | Ohtuvayre |
| Bayer Healthcare Pharmaceuticals INC. | $17.88 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.70 | 2024 | Caplyta |
| Idorsia Pharmaceuticals US INC | $17.55 | 2022 | |
| Exact Sciences Corporation | $16.47 | 2025 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $15.41 | 2024 | Eliquis |
| Glaxosmithkline, LLC. | $14.88 | 2022 | |
| Genentech USA, INC. | $10.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabe Robin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.